Endosonics has received Food and Drug Administration approvalfor its latest version of the Oracle Micro line of ultrasoundimaging catheters. The Pleasanton, CA, firm announced last monththat the FDA had given the go-ahead to Oracle Micro Plus,
Endosonics has received Food and Drug Administration approvalfor its latest version of the Oracle Micro line of ultrasoundimaging catheters. The Pleasanton, CA, firm announced last monththat the FDA had given the go-ahead to Oracle Micro Plus, whichcombines on a single catheter a solid-state imaging transducerand a percutaneous transluminal coronary angioplasty (PTCA) balloon.Endosonics said Oracle Micro Plus confers significant advantagesover its previous version of the product, which the FDA approvedlast year (SCAN 10/26/94). Oracle Micro Plus is especially wellsuited for coronary stenting procedures, the company said.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.